Matthew Merguerian

4PUBLICATIONS
30CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 08, 2025
Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in RUNX1-familial platelet disorder.

Mona Mohammadhosseini, Trevor Enright, Adam Duvall

|Sep 22, 2023
Natural history study of patients with familial platelet disorder with associated myeloid malignancy.

Lea Cunningham, Matthew Merguerian, Katherine R Calvo

|Jul 02, 2021
Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma.

Tingting Liu, Matthew D Merguerian, Steven P Rowe

Pageof 1